RXRX
Recursion
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
RXRX Profile
Recursion Pharmaceuticals, Inc.
A clinical-stage biotechnology company that develops technologies to enable drug discovery
Biological Technology
11/04/2013
04/16/2021
NASDAQ Stock Exchange
800
12-31
Common stock
41 S Rio Grande Street, Salt Lake City, UT 84101
--
Recursion Pharmaceuticals, Inc., was originally established on November 4, 2013 and is incorporated in Delaware. The company is a leading clinical-stage TechBio company that decodes biology to industrialize drug discovery. At the heart of the company's mission is the Recursive Operating System (OS), a platform built across multiple technologies that enables the company to map and navigate trillions of biological, chemical and patient-centric relationships in over 50 petabytes of proprietary data. The company frames this integration of physical and digital components as an iterative loop in which large-scale "wet lab" biological, chemical and patient-centric experimental data are organized by "dry lab" computing tools in order to identify, validate and translate therapeutic insights.